TNF Pharmaceuticals amends bylaws to lower stockholder vote threshold for non-director matters

Q/C TECHNOLOGIES, INC.

Board approved First Amendment to Bylaws on May 9, 2025, effective immediately.
For non-director matters, vote required reduced from majority of voting power present to majority of votes cast (excluding abstentions and broker non-votes).
Corresponding change made for class votes on non-director matters.
Director election standard remains plurality of voting power present.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Q/C TECHNOLOGIES, INC.: Lowered the required stockholder vote for matters other than election of directors from majority of voting power of shares present to majority of votes cast, excluding abstentions and broker non-votes; made corresponding change for class votes (effective 2025-05-09).

Change: bylaw amendment
Effective: 2025-05-09

Exact text from the filing

On May 9, 2025, the board of directors of TNF Pharmaceuticals, Inc. (the “Company”) approved the first amendment (the “First Amendment”) to the bylaws of the Company (the “Bylaws”), effective as of May 9, 2025.

View on SEC.gov

Browse all governance changes →

Q/C TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-009514

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.